Zhang, Yaowen
Belayachi, Jihane
Yang, Yunkai
Fu, Qiang
Rodewald, Lance
Li, Hongling
Yan, Bing
Wang, Ying
Shen, Yanna
Yang, Qian
Mu, Weiyun
Tang, Rong
Su, Chen
Xu, Tianfang
Obtel, Majdouline
Mhayi, Abdelkader
Razine, Rachid
Abouqal, Redouane
Zhang, Yuntao
Yang, Xiaoming
Article History
Received: 28 April 2022
Accepted: 11 August 2022
First Online: 20 August 2022
Declarations
:
: The study was approved by the Rabat Ethics Committee for Biomedical Research, University Mohammed V, Faculty of Medicine (Rabat, Morocco). A waiver of informed consent was granted for this observational study. Authorization from the National Control Commission for the Protection of Personal Data (CNDP) was also obtained. All methods were performed in accordance with the relevant guidelines and regulation.
: Not applicable.
: Yaowen Zhang, Yunkai Yang, Hongling Li, Yanna Shen, Qian Yang, Weiyun Mu, Rong Tang, Tianfang Xu, Yuntao Zhang and Xiaoming Yang are employees of China National Biotec Group Company Limited. Qiang Fu, Bing Yan, Ying Wang and Chen Su are employees of China Sinopharm International Corporation. Both companies are wholly-owned subsidiaries of China National Pharmaceutical Group Co., Ltd. (Sinopharm). The rest of the authors declare no conflict of interest.